Skip to main content

Evoke Pharma Inc

EVOKDelisted Dec 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001403708

Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Evoke Pharma Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of EVOK: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders1311−2
Shares70.5K62.6K−7.93K (−11.2%)
Value$228.0K$117.0K−$111.0K (−48.7%)

New holders (1)

Institutions that held Evoke Pharma Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to EVOK in Q3 2022
InstitutionSharesValue% of portfolio
Morgan Stanley1$00.00%

Sold out (3)

Institutions that held Evoke Pharma Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of EVOK in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Citigroup Inc812$3.00K
Bank of America Corp125$0
Advisor Group Holdings, Inc.41$0